搜尋結果

"" 的搜尋結果

Artificial Intelligence and Disability: How Can AI Promote Inclusion and Equity for Disabled People?

Video recording (click here to watch on YouTube): Abstract: Artificial intelligence (AI) is considered to hold great promise for health research and care in a wide range of applications. This promise is often assumed to extend into the realm of disability as well, especially in the development of assistive technologies that incorporate AI and automated decision making (ADM) to improve their function. At the same time, the use of AI in the provision of disability services can also present...

2025年 4月 7日

(Supporting Organisation) Allied World Webinar: Challenges of AI in Healthcare [CME]

Programme: HERE Science and technology in healthcare has advanced rapidly including the use of Artificial Intelligence (AI). The use of AI is now a growing trend in healthcare delivery under different branding such as “Smart Health”, “Smart Hospital”, “E-health”, “Digital Health” etc. AI applications can be very broad and not only restricted to diagnosis and monitoring in patient care, but also used for system management in healthcare setting. AI has the potential in precision medicine and...

2025年 3月 31日

(Co-organised) Lunch Seminar: The Medical Relevance of Social Isolation and Loneliness

(Open to HKU members only) Loneliness has emerged as a significant public health concern, with evidence linking it to increased risks of cardiovascular disease, depression, cognitive decline, and premature mortality. Research suggests that lacking social connection can be as detrimental to health as other leading risk factors, underscoring the urgent need for intervention. Despite its well-documented influence on health, social connection remains underrecognized and under-addressed within...

2025年 3月 28日

《以能力取向發展全球健康倡議，以促進公平獲取疫苗》

This volume assesses the role of intellectual property in pandemic times through lessons learned from COVID-19. Authored by an international roster of experts, chapters diagnose causes for the inequitable distribution of lifesaving COVID-19 vaccines and offer concrete suggestions for reform. From delinking vaccine development from monopoly rights in technology, to enhanced legal requirements under national and international law for sharing publicly funded technologies, to requiring funding from rich nations to former colonies to build local vaccine manufacturing capacity in low and middle-income countries (including those in Africa), this work highlights timely IP reforms that prepare us for the next pandemic. This title is also available as Open Access on Cambridge Core.

2025年 3月 27日
返回
Skip to content